145 related articles for article (PubMed ID: 22941581)
1. Outcome of patients after market withdrawal of thioridazine: a retrospective analysis in a nationwide cohort.
Purhonen M; Koponen H; Tiihonen J; Tanskanen A
Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1227-31. PubMed ID: 22941581
[TBL] [Abstract][Full Text] [Related]
2. Association between second-generation antipsychotic medication half-life and hospitalization in the community treatment of adult schizophrenia.
Broder MS; Bates JA; Jing Y; Hebden T; Forbes RA; Chang E
J Med Econ; 2012; 15(1):105-11. PubMed ID: 21991926
[TBL] [Abstract][Full Text] [Related]
3. The association between class of antipsychotic and rates of hospitalization: results of a retrospective analysis of data from the 2005 Medicare current beneficiary survey.
Kennedy J; Tien YY; Cohen LJ; Sclar DA; Liu D; Blodgett EG; Engle J
Clin Ther; 2009 Dec; 31(12):2931-9. PubMed ID: 20110033
[TBL] [Abstract][Full Text] [Related]
4. Changes in physicians' practice of prescribing cyclooxygenase-2 inhibitor after market withdrawal of rofecoxib: a retrospective study of physician-patient pairs in Taiwan.
Hsiao FY; Tsai YW; Huang WF
Clin Ther; 2009 Nov; 31(11):2618-27. PubMed ID: 20110006
[TBL] [Abstract][Full Text] [Related]
5. [Repercussions of the withdrawal of thioridazine].
Buj Alvarez I; Pifarré Paredero J; Idini E; Puigdevall Ruestes M
Actas Esp Psiquiatr; 2008; 36(3):183-6. PubMed ID: 18478459
[TBL] [Abstract][Full Text] [Related]
6. Risk of cerebrovascular adverse events in older adults using antipsychotic agents: a propensity-matched retrospective cohort study.
Mehta S; Johnson ML; Chen H; Aparasu RR
J Clin Psychiatry; 2010 Jun; 71(6):689-98. PubMed ID: 20573328
[TBL] [Abstract][Full Text] [Related]
7. A chemotherapeutic alternative to the antianxiety agents for the extended treatment of psychoneurosis.
Lofft JG; Demars JP
Dis Nerv Syst; 1974 Sep; 35(9):409-15. PubMed ID: 17894066
[No Abstract] [Full Text] [Related]
8. Low-dose imipramine for thioridazine-induced male orgasmic disorder.
Aizenberg D; Shiloh R; Zemishlany Z; Weizman A
J Sex Marital Ther; 1996; 22(3):225-9. PubMed ID: 8880656
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of acute schizophrenia with sulforidazine].
Sánchez E; Ning JL; Núñez H; Medina E
Rev Neuropsiquiatr; 1975 Jun; 38(2):94-105. PubMed ID: 1839
[No Abstract] [Full Text] [Related]
10. Monotherapy versus polypharmacy for hospitalized psychiatric patients.
Strous RD; Lerner V
Am J Psychiatry; 2005 Mar; 162(3):631-2; author reply 632-3. PubMed ID: 15741496
[No Abstract] [Full Text] [Related]
11. A controlled, mirror-image study of second-generation antipsychotics in the treatment of schizophrenia.
Taylor D; Hayhurst K; Kerwin R
Int Clin Psychopharmacol; 2007 May; 22(3):133-6. PubMed ID: 17414738
[TBL] [Abstract][Full Text] [Related]
12. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC
Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734
[TBL] [Abstract][Full Text] [Related]
13. Thioridazine and severe cardiac arrhythmia.
Prescrire Int; 2001 Dec; 10(56):183-4. PubMed ID: 11824444
[TBL] [Abstract][Full Text] [Related]
14. Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients.
Aparasu RR; Jano E; Johnson ML; Chen H
Am J Geriatr Pharmacother; 2008 Oct; 6(4):198-204. PubMed ID: 19028375
[TBL] [Abstract][Full Text] [Related]
15. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
[TBL] [Abstract][Full Text] [Related]
16. Compliance with refilling prescriptions for atypical antipsychotic agents and its association with the risks for hospitalization, suicide, and death in patients with schizophrenia in Quebec and Saskatchewan: a retrospective database study.
Ward A; Ishak K; Proskorovsky I; Caro J
Clin Ther; 2006 Nov; 28(11):1912-21. PubMed ID: 17213012
[TBL] [Abstract][Full Text] [Related]
17. Thioridazine inhibits risperidone metabolism: a clinically relevant drug interaction.
Nakagami T; Yasui-Furukori N; Saito M; Mihara K; De Vries R; Kondo T; Kaneko S
J Clin Psychopharmacol; 2005 Feb; 25(1):89-91. PubMed ID: 15643105
[No Abstract] [Full Text] [Related]
18. Concomitant use of thioridazine with risperidone.
Goss JB
Am J Health Syst Pharm; 1995 May; 52(9):1012. PubMed ID: 7543812
[No Abstract] [Full Text] [Related]
19. Monotherapy versus polypharmacy for hospitalized psychiatric patients.
Citrome L; Jaffe A; Levine J
Am J Psychiatry; 2005 Mar; 162(3):631; author reply 632-3. PubMed ID: 15741497
[No Abstract] [Full Text] [Related]
20. [Thioridazine and the warning about prolonged QT time].
Laisalmi M
Duodecim; 2002; 118(24):2518. PubMed ID: 12572286
[No Abstract] [Full Text] [Related]
[Next] [New Search]
